Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients69

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients17

Views

Views
November 20257
December 20252
January 20260
February 20261
March 20263
April 20262
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil3
United Kingdom3
Argentina3
United States2
Peru2
China1
Colombia1
Finland1
France1
 

Top cities views

Views
Ashburn1
Buenos Aires1
Catamarca1
Comas1
Ezeiza1
Helsinki1
Itabaianinha1
Jaraguá1
Lima1
Pasto1